Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Decibel Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +3 vs. Q1 2022
- Shares held
- 17.9M
- +178.0K (+1.0%) vs. Q1 2022
- Total value
- $75.2M
- +$21.4M (+39.9%) vs. Q1 2022
- New holders
- 10
- 9 more added
- Sold out
- 7
- 11 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $36.4K |
| Q3 2023 | 1 | $36.4K |
| Q2 2023 | 37 | $59.2M |
| Q1 2023 | 38 | $46.7M |
| Q4 2022 | 39 | $35.8M |
| Q3 2022 | 40 | $62.1M |
| Q2 2022 | 42 | $75.2M |
| Q1 2022 | 39 | $53.8M |
| Q4 2021 | 40 | $81.7M |
| Q3 2021 | 36 | $145.9M |
| Q2 2021 | 46 | $168.1M |
| Q1 2021 | 54 | $226.3M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Decibel Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 4,945,192 | $20.8M | 0.40% | 00.0% | Unchanged |
| TRV GP III, LLC | 3,139,685 | $13.2M | 5.41% | 00.0% | Unchanged |
| BlackRock Inc. | 1,894,481 | $7.98M | 0.00% | −2,742−0.1% | Reduced |
| Citadel Advisors LLC | 1,792,308 | $7.55M | 0.01% | +18,617+1.0% | Added |
| Alphabet Inc. | 1,636,258 | $6.89M | 0.37% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 801,629 | $3.38M | 0.90% | −24,793−3.0% | Reduced |
| Vanguard Group Inc | 622,937 | $2.62M | 0.00% | 00.0% | Unchanged |
| Bessemer Group Inc | 494,071 | $2.08M | 0.01% | 00.0% | Unchanged |
| Harvard Management Co Inc | 328,798 | $1.38M | 0.16% | 00.0% | Unchanged |
| Newtyn Management, LLC | 310,000 | $1.30M | 0.25% | +310,000 | New |
| Millennium Management LLC | 264,572 | $1.11M | 0.00% | +225,498+577.1% | Added |
| EAM Investors, LLC | 254,981 | $1.07M | 0.26% | +254,981 | New |
| Barclays PLC | 239,477 | $1.01M | 0.00% | −860−0.4% | Reduced |
| ExodusPoint Capital Management, LP | 225,000 | $947.0K | 0.01% | +225,000 | New |
| Bronte Capital Management Pty Ltd. | 163,547 | $689.0K | 0.08% | +323+0.2% | Added |
| JPMorgan Chase & Co | 148,224 | $624.0K | 0.00% | −8,145−5.2% | Reduced |
| Bridgeway Capital Management, LLC | 111,982 | $471.0K | 0.01% | −2,946−2.6% | Reduced |
| UBS Oconnor LLC | 87,745 | $369.0K | 0.00% | +87,745 | New |
| Geode Capital Management, LLC | 70,803 | $298.0K | 0.00% | +1,520+2.2% | Added |
| Neuberger Berman Group LLC | 69,000 | $290.0K | 0.00% | +6,175+9.8% | Added |
| Renaissance Technologies LLC | 27,600 | $116.0K | 0.00% | +6,685+32.0% | Added |
| Bank of New York Mellon Corp | 27,310 | $115.0K | 0.00% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 25,704 | $108.0K | 0.03% | 00.0% | Unchanged |
| Atlas Capital Advisors LLC | 25,000 | $105.3K | 0.02% | −16,025−39.1% | Reduced |
| Federated Hermes, Inc. | 20,000 | $84.0K | 0.00% | +5,000+33.3% | Added |
| Two Sigma Securities, LLC | 17,683 | $74.0K | 0.01% | +17,683 | New |
| State Street Corp | 17,160 | $72.0K | 0.00% | +900+5.5% | Added |
| Spire Wealth Management | 16,600 | $70.0K | 0.00% | +16,600 | New |
| MYDA Advisors LLC | 15,000 | $63.0K | 0.03% | −5,000−25.0% | Reduced |
| Northern Trust Corp | 14,239 | $60.0K | 0.00% | 00.0% | Unchanged |
| Laurion Capital Management LP | 11,990 | $50.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 11,029 | $46.0K | 0.00% | −11,812−51.7% | Reduced |
| Bank of America Corp | 10,947 | $46.0K | 0.00% | −7,742−41.4% | Reduced |
| CSS LLC | 10,800 | $45.0K | 0.00% | +10,800 | New |
| Flagship Harbor Advisors, LLC | 10,113 | $43.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 2,169 | $9.00K | 0.00% | +1,638+308.5% | Added |
| UBS Group AG | 1,504 | $6.00K | 0.00% | +1,504 | New |
| Acadian Asset Management LLC | 1,240 | $5.00K | 0.00% | −3,043−71.0% | Reduced |
| Simplex Trading, LLC | 1,102 | $4.00K | 0.00% | +1,102 | New |
| Tower Research Capital LLC (TRC) | 616 | $2.00K | 0.00% | −78−11.2% | Reduced |
| Financial Connections Group, Inc. | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 48 | $0 | 0.00% | +48 | New |
| Casdin Capital, LLC | 0 | $0 | 0.00% | −330,000−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −275,001−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −263,600−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −22,308−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −19,700−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,846−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −3,200−100.0% | Sold out |